Form 4: Veracyte CAO Disposes Shares for Tax Obligations

Chief Accounting Officer Jonathan Wygant had 1,361 shares withheld to satisfy tax liabilities following the vesting of restricted stock units.

Summary

• Jonathan Wygant, VP and Chief Accounting Officer, underwent a mandatory share withholding on June 2, 2026.
• A total of 1,361 shares of common stock were withheld by the company to cover tax withholding obligations.
• The transaction was executed at a price of $47.80 per share.
• The total value of the shares withheld for taxes is approximately $65,055.80.
• Following this transaction, Wygant retains direct ownership of 44,073 shares of Veracyte common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, administrative event. It is a standard part of executive compensation and does not reflect a change in the company's fundamental outlook or the executive's confidence in the firm.

Positives

• The reporting person maintains a significant equity stake in the company with over 44,000 shares held directly.
• The disposal was not an open-market sale, but rather a routine administrative transaction to satisfy tax requirements.
• The transaction indicates that restricted stock units (RSUs) are successfully vesting, suggesting the executive has met service or performance milestones.

Negatives

• There are no specific negatives identified in this routine administrative filing.

Risks

• No specific business or financial risks were disclosed in this Form 4 filing.

Future Outlook

The filing does not provide specific forward-looking guidance or a future outlook for the company's operations.

Management Comments

• The transaction represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units and does not represent a sale.

Industry Context

StockSavvy.ai notes that in the genomic diagnostics and biotechnology sectors, equity-based compensation is a standard tool for retaining key executive talent. This transaction is a routine occurrence following the vesting of equity grants.

Comparison to Industry Standards

• The use of share withholding (Code F) is a standard industry practice for managing executive tax liabilities, preferred by many firms over 'sell-to-cover' programs to reduce immediate market sell pressure.
• The CAO's ownership level is consistent with executive holdings in mid-cap healthcare technology companies.

Related Party Transactions

• The transaction itself is a related party transaction involving the company withholding shares from an officer to satisfy tax debts.

Stakeholder Impact

• Minimal impact on shareholders as the shares were withheld by the company rather than sold into the open market.

Next Steps

• No future actions or milestones were mentioned in this filing.

Key Dates

Keywords

Veracyte, VCYT, Insider Trading, Form 4, Jonathan Wygant, Chief Accounting Officer, Restricted Stock Units, Tax Withholding, Genomic Diagnostics